用冠状动脉心脏病患者的辅助决策来促进共享决策的干预措施:系统审查和元分析
Haoyang Zheng1, Duo Zhang2, Wei Xiang1
1Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, 430022 Wuhan, Hubei, China.
Reviews in cardiovascular medicine
|July 30, 2024
概括
使用患者决策辅助器的共享决策 (SDM) 提高了患者冠心病 (CHD) 患者的知识并减少了冲突. 这种方法提高了心血管疾病管理中的决策质量和治疗结果.
科学领域:
- 心脏病学 心脏病学
- 健康决策科学健康科学
- 基于证据的医学基于证据的医学.
背景情况:
- 冠心病 (CHD) 是全球主要的死亡原因.
- 管理心血管疾病涉及到关于胸痛,治疗和支架选择的复杂决策,常常因患者的不稳定状况而复杂化.
- 使用决策辅助工具的共享决策 (SDM) 可以提高决策质量,但尚未在CHD中进行评估.
研究的目的:
- 系统地审查和评估SDM干预措施对冠心病患者的影响.
- 评估SDM对心血管疾病患者决策质量和治疗结果的影响.
主要方法:
- 一个系统的审查和随机对照试验 (RCTs) 的SDM干预在心脏病患者的元分析.
- 从创立到2022年6月,搜索了多个数据库 (PubMed,Embase,Cochrane,Web of Science,CNKI,Wan Fang) 从创立到2022年6月.
- 主要结果:患者的知识和决策冲突. 二次结果:满意度,参与度,信任度,接受度,生活质量和心理状况.
主要成果:
- 包含了10项涉及8244个检索文章的研究.
- 与对照组相比,SDM干预显著改善了患者的知识,决策满意度,参与度和医疗结果.
- SDM干预措施有效地减少了决策冲突,但对患者的信任没有重大影响.
结论:
- SDM干预措施,特别是使用患者决策辅助工具,有利于改善心脏病患者的决策质量和治疗结果.
- 进一步评估SDM干预措施在不同的环境中是有必要的,以确认这些好处.
相关概念视频
01:22Heart Failure Drugs: β-Blockers
332
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
332
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
413
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
413
01:22Heart Failure Drugs: Diuretics
355
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
355
01:30Ethical Dilemmas II
971
Resolving an ethical dilemma in healthcare involves a systematic approach that considers every aspect of the issue, respecting both the patient's needs and values and the healthcare professional's ethical obligations. Here are potential steps to resolve an ethical dilemma:
971
01:26Heart Failure Drugs: Inotropic Agents
555
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
555
01:13Patient-centered Care
2.0K
Patient-centered care involves delivering care beyond inpatient hospitalization. Reflective practice can enhance a patient-centered approach. Reflective practice is a process of reasoning that considers all aspects of the present situation, including practicalities, learning from personal practice, and consideration of patient needs. Patients appreciate care decisions made while considering their input. Involving the patient in their care provides the patient with a sense of contribution rather...
2.0K